Cargando…

Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with (90)Y and (111)In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin’s Lymphoma

BACKGROUND: On the basis of results of our previous investigations on (90)Y-DTPA-rituximab and in order to fulfil national demands to radioimmunoconjugates for radioscintigraphy and radioimmunotherapy of Non-Hodgkin’s Lymphoma (NHL), preparation and radiolabeling of a lyophilized formulation (kit) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gholipour, Nazila, Jalilian, Amir Reza, Khalaj, Ali, Johari-Daha, Fariba, Yavari, Kamal, Sabzevari, Omid, Khanchi, Ali Reza, Akhlaghi, Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261883/ https://www.ncbi.nlm.nih.gov/pubmed/25074720 http://dx.doi.org/10.1186/2008-2231-22-58

Ejemplares similares

Preparation and Biological Study of (68)Ga-DOTA-alendronate
por: Fakhari, Ashraf, et al.
Publicado: (2016)

Development of DOTA-Rituximab to be Labeled with (90)Y for Radioimmunotherapy of B-cell Non-Hodgkin Lymphoma
por: Johari doha, Fariba, et al.
Publicado: (2017)

Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging
por: Firuzyar, Tahereh, et al.
Publicado: (2016)

Synthesis, Radiolabeling and Biological Evaluation of (99m)Tc-labeled Deoxyglucose Derivatives for Molecular Imaging
por: Sadeghzadeh, Masoud, et al.
Publicado: (2013)

Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy
por: Uccelli, Licia, et al.
Publicado: (2017)

Synthesis and evaluation of (99m)Tc-DOTA-ARA-290 as potential SPECT tracer for targeting cardiac ischemic region
por: Mohtavinejad, Naser, et al.
Publicado: (2021)

Preparation, Biological Evaluation and Dosimetry Studies of 175Yb-Bis-Phosphonates for Palliative Treatment of Bone Pain
por: Fakhari, Ashraf, et al.
Publicado: (2015)

(99m)Tc-radiolabeled GE11-modified peptide for ovarian tumor targeting
por: Rahmanian, Najmeh, et al.
Publicado: (2017)

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
por: Dillman, R. O.
Publicado: (2006)

Alpha radioimmunotherapy using (225)Ac-proteus-DOTA for solid tumors - safety at curative doses
por: Cheal, Sarah M., et al.
Publicado: (2020)

Comparison of the radiolabeled PSMA-inhibitor (111)In-PSMA-617 and the radiolabeled GRP-R antagonist (111)In-RM2 in primary prostate cancer samples
por: Schollhammer, Romain, et al.
Publicado: (2019)

Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications
por: Laudicella, Riccardo, et al.
Publicado: (2019)

Synthesis of DOTA-pyridine chelates for (64)Cu coordination and radiolabeling of αMSH peptide
por: Yang, Hua, et al.
Publicado: (2021)

Imaging of Clot by (99m)Tc-HMPAO Labeled Platelet in Animal Model Induced Thrombosis
por: Parvizi, Mahdieh, et al.
Publicado: (2020)

Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations
por: Ghoreishi, Seyedeh Masoumeh, et al.
Publicado: (2018)

Experimental α-particle radioimmunotherapy of breast cancer using (227)Th-labeled p-benzyl-DOTA-trastuzumab
por: Abbas, Nasir, et al.
Publicado: (2011)

(68)Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation
por: Hajiramezanali, Maliheh, et al.
Publicado: (2019)

Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers
por: Jussing, Emma, et al.
Publicado: (2021)

Development of [(225)Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration
por: Hull, Ashleigh, et al.
Publicado: (2023)

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
por: Brom, Maarten, et al.
Publicado: (2012)

Imaging inflammation in atherosclerotic plaques, targeting SST(2) with [(111)In]In-DOTA-JR11
por: Meester, Eric J., et al.
Publicado: (2020)

In vitro characterisation of [(177)Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer
por: Hull, Ashleigh, et al.
Publicado: (2023)

Optimization of Radiolabeling of a [(90)Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation
por: Winter, Gordon, et al.
Publicado: (2023)

Production and Quality Control of [(67)Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy
por: Alirezapour, Behrooz, et al.
Publicado: (2013)

Physicochemical Evaluation of Lyophilized Formulation of p-SCN-Bn-DOTA- and p-SCN-Bn-DTPA-rituximab for NHL Radio Immunotherapy
por: Ackova, Darinka Gjorgieva, et al.
Publicado: (2016)

Synthesis and Radiolabelling of DOTA-Linked Glutamine Analogues with (67,68)Ga as Markers for Increased Glutamine Metabolism in Tumour Cells
por: Pellegrini, Paul A., et al.
Publicado: (2013)

Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [(64)Cu]Cu-DOTA-TOC
por: Vahidfar, Nasim, et al.
Publicado: (2022)

Evaluation and comparison of human absorbed dose of (90)Y-DOTA-Cetuximab in various age groups based on distribution data in rats
por: Vakili, Ariandokht, et al.
Publicado: (2012)

In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes
por: Potts, Jonathan R., et al.
Publicado: (2018)

Effect of coating thickness of iron oxide nanoparticles on their relaxivity in the MRI
por: Hajesmaeelzadeh, Farzaneh, et al.
Publicado: (2016)

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: de Keizer, Bart, et al.
Publicado: (2008)

Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method
por: Mueller, Dirk, et al.
Publicado: (2016)

Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
por: O'Byrne, K. J., et al.
Publicado: (1994)

[(111)In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study
por: Tatsi, Aikaterini, et al.
Publicado: (2012)

Development of Novel (111)-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
por: Poret, Benjamin, et al.
Publicado: (2020)

Evaluation of a (68)Ga-Labeled DOTA-Tetrazine as a PET Alternative to (111)In-SPECT Pretargeted Imaging
por: Edem, Patricia E., et al.
Publicado: (2020)

An approach for conjugation of (177)Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients
por: Thakral, Parul, et al.
Publicado: (2014)

In Vitro Characterization of (177)Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
por: Mohajershojai, Tabassom, et al.
Publicado: (2022)

Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
por: Opalinska, Marta, et al.
Publicado: (2023)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
por: Sabanathan, Dhanusha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ehtdsbnsc8pcu8lpncppqmbf6p